This announcement is a separate document:
Delta-Fly Pharma：DFP-10917とVTXの臨床第1／2相試験プロトコールのFDA提出に関するお知らせ
Delta-Fly Pharma: Notice Concerning FDA Submission of Clinical Phase 1 and 2 Trial Protocols for DFP-10917 and VTX
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.